Aug. KFDA approval of InduCera, dual coated bone graft
Jun. Min. of knowledge & Economy grant on ODS project for int’l collaboration R&D
2009
Jun. First Dosing for Phase I clinical study of Of OCT-1547, new drug candidate for the treatment of osteoporosis
May IND and CTA of OCT-1547, new drug candidate for the treatment of osteoporosis
May Fund of Ministry For Health, Welfare And Family Affairs for the clinical study of OCT-1547, new drug candidate for the treatment of osteoporosis
Mar. Renaming of OCT USA Inc. – GENOSCO
2008
Dec. Fund of Ministry Of Education, Science And Technology for the new drug development for the treatment of rheumatoid arthritis
Aug Fund of Small And Medium Business Administration for the new drug development for the treatment of arthritis through molecular design
Jun Consulting Agreement for the IND and CTA of OCT-1547. New drug candidate for the treatment of osteoporosis, with Kendle International Inc.
2007
Sep. Collaborative Research Agreement for the new drug development for the treatment of osteoporosis with Children`s Hospital Boston, the primary pediatric teaching hospital of Harvard Medical School